Health ❯ Patient Care ❯ Chronic Illness

Treatment Options

Acromegaly Management Steroid-Sparing Treatments

FDA Approves Palsonify, First Once-Daily Oral Treatment for Acromegaly

Crinetics targets an early-October U.S. launch supported by its CrinetiCARE access program.

EU Regulators Back Uplizna as First Treatment for IgG4‑Related Disease